Millennium Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Millennium Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-20,000	Closed	-$4.14M	–	4088
2019 Q4	$4.14M	Buy	+20,000	New	+$3.7M	0.01%	2083

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

DCM

DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Millennium Management's LKFT Position: Q2 2026 in Review

Millennium Management increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 68% in Q2 2026, buying an estimated $2.08M and bringing the position to 181,090 shares worth $5.43M. The position accounts for ﹤0.01% of the portfolio, ranked #2927.

Millennium Management first reported a position in LKFT in Q2 2015 and has held it in 36 quarters since. The position peaked at $19.5M in Q1 2022. 76 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

Millennium Management held 181,090 shares of Lakefront Biotherapeutics American Depositary Shares worth $5.43M as of Q2 2026.
Millennium Management bought 73,178 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $2.08M.
Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Millennium Management's portfolio in Q2 2026, its #2927 holding.
Millennium Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2015 and has held it in 36 quarters since.
Millennium Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $19.5M in Q1 2022.
76 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.